Position in VERA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,835,212
-$10,467,820 QoQ
Shares Held
368,760
-26.2% QoQ
Ownership
0.514%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 96.40986007159128.ToString("F0")%
Shared 0.ToString("F0")%
None 3.590139928408721.ToString("F0")%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. VERA ranks #112 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in VERA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,835,212 | 368,760 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,303,032 | 499,665 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $7,977,634 | 274,523 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $52,733,213 | 2,238,252 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $10,585,347 | 440,689 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $13,892,894 | 328,515 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $15,075,554 | 341,076 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $11,050,742 | 305,438 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $66,266,382 | 1,536,790 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $15,300,636 | 994,840 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $12,541,164 | 914,746 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $15,537,119 | 968,045 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $315,581 | 40,668 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $300,947 | 15,553 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $489,275 | 22,960 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $47,157 | 3,465 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $434,986 | 18,518 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $713,181 | 26,691 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $381,803 | 22,006 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $23,655 | 1,784 | Shares | Defined | 2021-08-23 | |
| No filing history on record for this holder in this stock. | ||||||